Skip to content
10-Q

Quarterly Report

RESEARCH FRONTIERS INCORPORATED REFR

0001493152-24-018416

← back to feed
Filed
May 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 9, 2024 33.52M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $2.09M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $2.48M
Current Liabilities Q1 2024 · Mar 31, 2024 $439.45K
Current Liabilities Q1 2024 · Dec 31, 2023 $277.43K
Total Liabilities Q1 2024 · Mar 31, 2024 $439.45K
Total Liabilities Q1 2024 · Dec 31, 2023 $332.79K
Current Assets Q1 2024 · Mar 31, 2024 $3.29M
Current Assets Q1 2024 · Dec 31, 2023 $3.58M
Total Assets Q1 2024 · Mar 31, 2024 $3.52M
Total Assets Q1 2024 · Dec 31, 2023 $3.85M
Shares Diluted Q1 2024 · Mar 31, 2023 33.29M sh
Capex Q1 2024 · Mar 31, 2023 $702
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$597.12K
Stockholders Equity Q1 2024 · Mar 31, 2023 $4.82M
Stockholders Equity Q1 2024 · Dec 31, 2022 $4.8M
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.01
Eps Basic Q1 2024 · Mar 31, 2023 −$0.01
Rd Expense Q1 2024 · Mar 31, 2023 $149.22K
Net Income Q1 2024 · Mar 31, 2023 −$462.64K
Operating Income Q1 2024 · Mar 31, 2023 −$488.85K
Revenue Q1 2024 · Mar 31, 2023 $248.18K